Abstract
The impact of exercise on mental health, on cognition, brain function and brain structure as well as the possible underlying molecular systems important for maintaining neural function and plasticity has been extensively examined. Moreover, numerous studies have reinforced t the important and beneficial role of exercise for those with neurological disorders. This article reviews general aspects of physical exercise against neurodegenerative diseases and the relevant contributions of physical exercise programs as complementary therapy for epilepsy. We first give an overview of the plasticity induced by exercise in the damaged brain, the impact of exercise in reducing brain injury as well as in delaying onset of and decline in several neurodegenerative diseases. We address the relationship between epilepsy and exercise and report the neuroprotective and antiepileptogenic effects of exercise on epilepsy based on experimental and clinical studies. Overall, we conclude that physical or sport activities represent an exciting intervention that should be integrated with conventional therapy for the improvement of brain function and resistance to neurodegenerative diseases as well as a complementary non-pharmacological treatment of epilepsy.
Keywords: Physical activity, exercise, brain injury, neurodegenerative diseases, epilepsy, seizure, neuroprotection
Current Pharmaceutical Design
Title:Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders
Volume: 19 Issue: 38
Author(s): Ricardo Mario Arida, Fulvio Alexandre Scorza and Esper Abrão Cavalheiro
Affiliation:
Keywords: Physical activity, exercise, brain injury, neurodegenerative diseases, epilepsy, seizure, neuroprotection
Abstract: The impact of exercise on mental health, on cognition, brain function and brain structure as well as the possible underlying molecular systems important for maintaining neural function and plasticity has been extensively examined. Moreover, numerous studies have reinforced t the important and beneficial role of exercise for those with neurological disorders. This article reviews general aspects of physical exercise against neurodegenerative diseases and the relevant contributions of physical exercise programs as complementary therapy for epilepsy. We first give an overview of the plasticity induced by exercise in the damaged brain, the impact of exercise in reducing brain injury as well as in delaying onset of and decline in several neurodegenerative diseases. We address the relationship between epilepsy and exercise and report the neuroprotective and antiepileptogenic effects of exercise on epilepsy based on experimental and clinical studies. Overall, we conclude that physical or sport activities represent an exciting intervention that should be integrated with conventional therapy for the improvement of brain function and resistance to neurodegenerative diseases as well as a complementary non-pharmacological treatment of epilepsy.
Export Options
About this article
Cite this article as:
Mario Arida Ricardo, Alexandre Scorza Fulvio and Abrão Cavalheiro Esper, Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders, Current Pharmaceutical Design 2013; 19 (38) . https://dx.doi.org/10.2174/1381612811319380004
DOI https://dx.doi.org/10.2174/1381612811319380004 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Neural Correlates in Patients with Major Affective Disorders: An fMRI Study
CNS & Neurological Disorders - Drug Targets Application of Pharmacophore Models for the Design and Synthesis of New Anticonvulsant Drugs
Mini-Reviews in Medicinal Chemistry Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies
Current Pharmaceutical Design Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies
Current Neuropharmacology Calcium Channels and Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery Anticonvulsant and Neurotoxicity of Some Novel 1-([1,3,4]thiadiazino[6,5- b]indol-3-yl Semicarbazides
Central Nervous System Agents in Medicinal Chemistry Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety High Throughput Electrophysiology with Xenopus Oocytes
Combinatorial Chemistry & High Throughput Screening Nitrogen, Oxygen or Sulfur Containing Heterocyclic Compounds as Analgesic Drugs Used as Modulators of the Nitroxidative Stress
Mini-Reviews in Medicinal Chemistry Molecular Therapeutics of HBV
Current Gene Therapy Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles
CNS & Neurological Disorders - Drug Targets What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology CNS Drug Development – Lost in Translation?
Mini-Reviews in Medicinal Chemistry Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy
Current Pharmaceutical Design Complications of Serogroup B Meningococcal Disease in Survivors: A Review
Infectious Disorders - Drug Targets